SCHLAGWORTE: Life Sciences
Cold plasma technology from Greifswald leads the world
neoplas med GmbH from Greifswald, Germany, is considered a pioneer in medical cold plasma therapy. The company has been setting standards since its foundation...
BioM veröffentlicht Jahresreport
Zusammen mit Dr. Manfred Wolter (Ministerialdirigent im Bayerischen Wirtschaftsministerium) stellte BioM in Martinsried seinen Jahresreport „Biotech in Bavaria 2024/25 – One World for Innovation“...
‘Germany plays a leading role in radiopharmaceutical therapy’
As the global demand for targeted cancer therapies increases, Germany is emerging as a powerhouse of radiopharmaceutical research and innovation. Playing a leading role...
ITM sichert sich bis zu 262,5 Mio. USD von Blue Owl...
Die Radiopharmazeutik-Biotechfirma ITM Isotope Technologies Munich SE aus Garching bei München hat eine Wachstumsfinanzierung in Höhe von bis zu USD 262,5 Mio. durch von...
30 Jahre IZB
Mit einer großen Feier und spannenden Diskussionen blickte das Innovations- und Gründerzentrum für Biotechnologie (IZB) am 22. Mai 2025 auf 30 Jahre Fortschritt zurück...
Now online: Second issue of „Impact Life Sciences“
In this issue's cover interview, Dr Andrew Cavey, CEO of ITM Isotope Technologies Munich SE, shares his views on Germany’s position as a biotech...
HAYA Therapeutics sichert sich 65 Mio. USD in Series-A-Runde
Das Schweizer Biotechnologieunternehmen HAYA Therapeutics SA hat erfolgreich eine Series-A-Finanzierungsrunde in Höhe von 65 Mio. USD abgeschlossen. Die Runde wurde von Sofinnova Partners und...
Nuclear medicine on the rise
Nuclear medicine is currently experiencing a dynamic resurgence, fuelled by groundbreaking innovations in theranostics, the rapid development of novel radiotracers, and the emergence of...
Health & Life Science Venture Day 2025
Auch im Jahr 2025 veranstaltet Life Science Nord den Health & Life Science Venture Day und bringt erneut die vielversprechendsten Startups aus Biotech, Pharma,...
Swiss Biotech Day 2025
Since 2021, the Swiss Biotech Day has grown 40% every year and has become a premier global biotechnology conference for life sciences professionals, fostering...
AI – hype or hope?
Artificial intelligence (AI) is here to stay. This technology and its use in drug development, respectively their protagonists, were awarded Nobel prizes in 2024....
Momentum recognised: Teams and portfolios are being expanded
There are many uncertainties in the world, but this much is certain: the demand for innovative life sciences solutions will continue to grow, from...
BayOConnect – Forum for Biotech & Life Science
Discover the future of biotechnology at BioM's networking conference in Munich! This year the events sets the focus on Global challenges for research &...
‘Germany has enormous potential in terms of basic research’
Life sciences expert Dr Achim Plum has been on the management team of High-Tech Gründerfonds (HTGF) since January 2025, strengthening the life sciences sector...
Regina Hodits neue Managing Director bei Angelini Ventures
Angelini Ventures, die Corporate-Venture-Firma von Angelini Industries, die in Start-ups in den Bereichen Biotechnologie und digitale Gesundheit investiert, gibt die Ernennung von Dr. Regina...